Pretreatment SUVmax predicts progression-free survival in early-stage non-small cell lung cancer treated with stereotactic body radiation therapy
2014 · Radiation Oncology · 49 citations
https://doi.org/10.1186/1748-717x-9-41
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
154
Papers
7.8K
Citations
41
h-index
79
i10-index
Neil A. Christie is an academic researcher from University of Pittsburgh. The author has contributed to research in topics: Lung Cancer Diagnosis and Treatment & Esophageal and GI Pathology & Lung Cancer Treatments and Mutations. The author has an h-index of 41, co-authored 131 publications.
https://doi.org/10.1186/1748-717x-9-41
https://doi.org/10.1385/ijgc:34:2-3:095
https://doi.org/10.1016/j.atssr.2024.10.011
Click to start Chat